01.26.17
Cyprotex, a company wholly owned by Evotec AG, has relocated its UK operations from Macclesfield to Alderley Park. The move consolidates Cyprotex’s UK operations into a single, state-of-the-art facility.
According to the company, Alderley Park is a growing and vibrant scientific hub, which is home to a network of over 150 biotech and life science companies. The facility to which Cyprotex has relocated to covers approximately 2,300 square meters of office and laboratory space and will accommodate all 106 of Cyprotex’s current UK staff.
"Moving to Alderley Park allows for the expansion and consolidation of Cyprotex’s UK operations into a first-class scientific facility, which of course will serve to benefit our client base,” said Mario Polywka, chief operating officer, Evotec. “This is an important step in the integration of Cyprotex into the Evotec Group, which is proceeding according to our plans.”
According to the company, Alderley Park is a growing and vibrant scientific hub, which is home to a network of over 150 biotech and life science companies. The facility to which Cyprotex has relocated to covers approximately 2,300 square meters of office and laboratory space and will accommodate all 106 of Cyprotex’s current UK staff.
"Moving to Alderley Park allows for the expansion and consolidation of Cyprotex’s UK operations into a first-class scientific facility, which of course will serve to benefit our client base,” said Mario Polywka, chief operating officer, Evotec. “This is an important step in the integration of Cyprotex into the Evotec Group, which is proceeding according to our plans.”
